ID   NNTM_HUMAN              Reviewed;        1086 AA.
AC   Q13423; Q16796; Q2TB60; Q8N3V4;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 3.
DT   10-MAY-2017, entry version 174.
DE   RecName: Full=NAD(P) transhydrogenase, mitochondrial;
DE            EC=1.6.1.2;
DE   AltName: Full=Nicotinamide nucleotide transhydrogenase;
DE   AltName: Full=Pyridine nucleotide transhydrogenase;
DE   Flags: Precursor;
GN   Name=NNT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9524818; DOI=10.3109/10425179709034058;
RA   Ware J., Zieger B.;
RT   "Cloning and deduced amino acid sequence of human nicotinamide
RT   nucleotide transhydrogenase.";
RL   DNA Seq. 7:369-374(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=8616157; DOI=10.1016/0005-2728(95)00159-X;
RA   Lagberg E.M., Betsholtz C., Rydstrom J.;
RT   "The cDNA sequence of proton-pumping nicotinamide nucleotide
RT   transhydrogenase from man and mouse.";
RL   Biochim. Biophys. Acta 1273:203-205(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70 AND LYS-397, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, AND VARIANTS GCCD4 ASN-193; ALA-357;
RP   PRO-365; LEU-437; VAL-533; ARG-664; ARG-678; ASP-862; PRO-977;
RP   PRO-1008 AND LYS-1009.
RX   PubMed=22634753; DOI=10.1038/ng.2299;
RA   Meimaridou E., Kowalczyk J., Guasti L., Hughes C.R., Wagner F.,
RA   Frommolt P., Nurnberg P., Mann N.P., Banerjee R., Saka H.N.,
RA   Chapple J.P., King P.J., Clark A.J., Metherell L.A.;
RT   "Mutations in NNT encoding nicotinamide nucleotide transhydrogenase
RT   cause familial glucocorticoid deficiency.";
RL   Nat. Genet. 44:740-742(2012).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 880-1086 IN COMPLEX WITH
RP   NADP.
RX   PubMed=10673423; DOI=10.1016/S0969-2126(00)00075-7;
RA   White S.A., Peake S.J., McSweeney S., Leonard G., Cotton N.P.J.,
RA   Jackson J.B.;
RT   "The high-resolution structure of the NADP(H)-binding component (dIII)
RT   of proton-translocating transhydrogenase from human heart
RT   mitochondria.";
RL   Structure 8:1-12(2000).
CC   -!- FUNCTION: The transhydrogenation between NADH and NADP is coupled
CC       to respiration and ATP hydrolysis and functions as a proton pump
CC       across the membrane. May play a role in reactive oxygen species
CC       (ROS) detoxification in the adrenal gland.
CC       {ECO:0000269|PubMed:22634753}.
CC   -!- CATALYTIC ACTIVITY: NADPH + NAD(+) = NADP(+) + NADH.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305};
CC       Multi-pass membrane protein {ECO:0000305}; Matrix side
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with expression most readily
CC       detectable in adrenal, heart, kidney, thyroid and adipose tissues.
CC       {ECO:0000269|PubMed:22634753}.
CC   -!- DISEASE: Glucocorticoid deficiency 4 with or without
CC       mineralocorticoid deficiency (GCCD4) [MIM:614736]: A rare,
CC       potentially lethal, autosomal recessive disorder characterized by
CC       resistance to ACTH action on the adrenal cortex, adrenal
CC       insufficiency and an inability of the adrenal cortex to produce
CC       cortisol. It usually presents in the neonatal period or in early
CC       childhood with episodes of hypoglycemia and other symptoms related
CC       to cortisol deficiency, including failure to thrive, recurrent
CC       illnesses or infections, convulsions, and shock. In a small number
CC       of patients hypoglycemia can be sufficiently severe and persistent
CC       that it leads to serious long-term neurological damage or death.
CC       The diagnosis is readily confirmed with a low plasma cortisol
CC       measurement in the presence of an elevated ACTH level, and normal
CC       aldosterone and plasma renin measurements.
CC       {ECO:0000269|PubMed:22634753}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the AlaDH/PNT
CC       family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the PNT beta
CC       subunit family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U40490; AAC51914.1; -; mRNA.
DR   EMBL; Z50101; CAA90428.1; -; mRNA.
DR   EMBL; AL831822; CAD38536.1; -; mRNA.
DR   EMBL; BC110543; AAI10544.1; -; mRNA.
DR   CCDS; CCDS3949.1; -.
DR   PIR; G02257; G02257.
DR   RefSeq; NP_036475.3; NM_012343.3.
DR   RefSeq; NP_892022.2; NM_182977.2.
DR   RefSeq; XP_005248331.1; XM_005248274.4.
DR   RefSeq; XP_011512303.1; XM_011514001.2.
DR   RefSeq; XP_016864782.1; XM_017009293.1.
DR   UniGene; Hs.482043; -.
DR   PDB; 1DJL; X-ray; 2.00 A; A/B=880-1086.
DR   PDB; 1PT9; X-ray; 2.42 A; A/B=880-1086.
DR   PDB; 1U31; X-ray; 2.20 A; A/B=880-1086.
DR   PDBsum; 1DJL; -.
DR   PDBsum; 1PT9; -.
DR   PDBsum; 1U31; -.
DR   ProteinModelPortal; Q13423; -.
DR   SMR; Q13423; -.
DR   BioGrid; 117076; 53.
DR   IntAct; Q13423; 19.
DR   MINT; MINT-3027647; -.
DR   STRING; 9606.ENSP00000264663; -.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB01763; 7-thionicotinamide-adenine-dinucleotide phosphate.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; Q13423; -.
DR   PhosphoSitePlus; Q13423; -.
DR   SwissPalm; Q13423; -.
DR   BioMuta; NNT; -.
DR   DMDM; 51338801; -.
DR   EPD; Q13423; -.
DR   MaxQB; Q13423; -.
DR   PaxDb; Q13423; -.
DR   PeptideAtlas; Q13423; -.
DR   PRIDE; Q13423; -.
DR   DNASU; 23530; -.
DR   Ensembl; ENST00000264663; ENSP00000264663; ENSG00000112992.
DR   Ensembl; ENST00000344920; ENSP00000343873; ENSG00000112992.
DR   GeneID; 23530; -.
DR   KEGG; hsa:23530; -.
DR   UCSC; uc003joe.4; human.
DR   CTD; 23530; -.
DR   DisGeNET; 23530; -.
DR   GeneCards; NNT; -.
DR   H-InvDB; HIX0032203; -.
DR   HGNC; HGNC:7863; NNT.
DR   HPA; CAB004975; -.
DR   HPA; HPA004829; -.
DR   MalaCards; NNT; -.
DR   MIM; 607878; gene.
DR   MIM; 614736; phenotype.
DR   neXtProt; NX_Q13423; -.
DR   OpenTargets; ENSG00000112992; -.
DR   Orphanet; 361; Familial glucocorticoid deficiency.
DR   PharmGKB; PA31667; -.
DR   eggNOG; ENOG410IEMU; Eukaryota.
DR   eggNOG; COG1282; LUCA.
DR   eggNOG; COG3288; LUCA.
DR   GeneTree; ENSGT00390000004624; -.
DR   HOGENOM; HOG000160623; -.
DR   HOVERGEN; HBG006511; -.
DR   InParanoid; Q13423; -.
DR   KO; K00323; -.
DR   OMA; KPGIPYK; -.
DR   OrthoDB; EOG091G01NO; -.
DR   PhylomeDB; Q13423; -.
DR   TreeFam; TF300636; -.
DR   BioCyc; MetaCyc:HS03639-MONOMER; -.
DR   BRENDA; 1.6.1.2; 2681.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   ChiTaRS; NNT; human.
DR   EvolutionaryTrace; Q13423; -.
DR   GeneWiki; NNT_(gene); -.
DR   GenomeRNAi; 23530; -.
DR   PRO; PR:Q13423; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000112992; -.
DR   CleanEx; HS_NNT; -.
DR   ExpressionAtlas; Q13423; baseline and differential.
DR   Genevisible; Q13423; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:UniProtKB.
DR   GO; GO:0005746; C:mitochondrial respiratory chain; TAS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:LIFEdb.
DR   GO; GO:0051287; F:NAD binding; TAS:UniProtKB.
DR   GO; GO:0008750; F:NAD(P)+ transhydrogenase (AB-specific) activity; IBA:GO_Central.
DR   GO; GO:0003957; F:NAD(P)+ transhydrogenase (B-specific) activity; TAS:UniProtKB.
DR   GO; GO:0008746; F:NAD(P)+ transhydrogenase activity; EXP:Reactome.
DR   GO; GO:0050661; F:NADP binding; IDA:UniProtKB.
DR   GO; GO:0006740; P:NADPH regeneration; IBA:GO_Central.
DR   GO; GO:0055114; P:oxidation-reduction process; TAS:UniProtKB.
DR   GO; GO:0015992; P:proton transport; TAS:UniProtKB.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IMP:UniProtKB.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; TAS:UniProtKB.
DR   Gene3D; 3.40.50.1220; -; 1.
DR   InterPro; IPR008143; Ala_DH/PNT_CS2.
DR   InterPro; IPR008142; AlaDH/PNT_CS1.
DR   InterPro; IPR007886; AlaDH/PNT_N.
DR   InterPro; IPR007698; AlaDH/PNT_NAD(H)-bd.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR026255; NADP_transhyd_a.
DR   InterPro; IPR024605; NADP_transhyd_a_C.
DR   InterPro; IPR034300; PNTB-like.
DR   Pfam; PF01262; AlaDh_PNT_C; 1.
DR   Pfam; PF05222; AlaDh_PNT_N; 1.
DR   Pfam; PF02233; PNTB; 1.
DR   Pfam; PF12769; PNTB_4TM; 1.
DR   SMART; SM01002; AlaDh_PNT_C; 1.
DR   SMART; SM01003; AlaDh_PNT_N; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF52467; SSF52467; 1.
DR   TIGRFAMs; TIGR00561; pntA; 1.
DR   PROSITE; PS00836; ALADH_PNT_1; 1.
DR   PROSITE; PS00837; ALADH_PNT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Disease mutation;
KW   Membrane; Mitochondrion; Mitochondrion inner membrane; NAD; NADP;
KW   Oxidoreductase; Reference proteome; Transit peptide; Transmembrane;
KW   Transmembrane helix.
FT   TRANSIT       1     43       Mitochondrion. {ECO:0000250}.
FT   CHAIN        44   1086       NAD(P) transhydrogenase, mitochondrial.
FT                                /FTId=PRO_0000001055.
FT   TOPO_DOM     44    474       Mitochondrial matrix.
FT   TRANSMEM    475    493       Helical. {ECO:0000255}.
FT   TRANSMEM    501    521       Helical. {ECO:0000255}.
FT   TRANSMEM    527    546       Helical. {ECO:0000255}.
FT   TRANSMEM    558    578       Helical. {ECO:0000255}.
FT   TOPO_DOM    579    595       Mitochondrial matrix.
FT   TRANSMEM    596    616       Helical. {ECO:0000255}.
FT   TRANSMEM    622    642       Helical. {ECO:0000255}.
FT   TRANSMEM    646    666       Helical. {ECO:0000255}.
FT   TRANSMEM    672    691       Helical. {ECO:0000255}.
FT   TRANSMEM    702    722       Helical. {ECO:0000255}.
FT   TOPO_DOM    723    739       Cytoplasmic.
FT   TRANSMEM    740    760       Helical. {ECO:0000255}.
FT   TRANSMEM    778    797       Helical. {ECO:0000255}.
FT   TRANSMEM    801    819       Helical. {ECO:0000255}.
FT   TRANSMEM    833    853       Helical. {ECO:0000255}.
FT   TRANSMEM    857    879       Helical. {ECO:0000255}.
FT   TOPO_DOM    880   1086       Mitochondrial matrix.
FT   NP_BIND     229    259       NAD. {ECO:0000250}.
FT   NP_BIND     965    970       NADP. {ECO:0000269|PubMed:10673423}.
FT   NP_BIND    1007   1011       NADP. {ECO:0000269|PubMed:10673423}.
FT   NP_BIND    1042   1049       NADP. {ECO:0000269|PubMed:10673423}.
FT   NP_BIND    1068   1069       NADP. {ECO:0000269|PubMed:10673423}.
FT   BINDING     933    933       NADP; via amide nitrogen.
FT                                {ECO:0000269|PubMed:10673423}.
FT   MOD_RES      70     70       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     117    117       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61941}.
FT   MOD_RES     224    224       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61941}.
FT   MOD_RES     294    294       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61941}.
FT   MOD_RES     331    331       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61941}.
FT   MOD_RES     397    397       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1079   1079       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61941}.
FT   VARIANT     193    193       S -> N (in GCCD4; dbSNP:rs867004061).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068781.
FT   VARIANT     357    357       T -> A (in GCCD4).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068782.
FT   VARIANT     365    365       H -> P (in GCCD4).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068783.
FT   VARIANT     437    437       P -> L (in GCCD4; dbSNP:rs781183677).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068784.
FT   VARIANT     533    533       A -> V (in GCCD4; dbSNP:rs387907232).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068785.
FT   VARIANT     664    664       G -> R (in GCCD4; dbSNP:rs371979800).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068786.
FT   VARIANT     678    678       G -> R (in GCCD4).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068787.
FT   VARIANT     862    862       G -> D (in GCCD4).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068788.
FT   VARIANT     977    977       L -> P (in GCCD4; dbSNP:rs387907233).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068789.
FT   VARIANT    1008   1008       A -> P (in GCCD4; dbSNP:rs387907234).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068790.
FT   VARIANT    1009   1009       N -> K (in GCCD4; dbSNP:rs370273690).
FT                                {ECO:0000269|PubMed:22634753}.
FT                                /FTId=VAR_068791.
FT   CONFLICT    176    176       A -> T (in Ref. 2; CAA90428).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       G -> E (in Ref. 3; CAD38536).
FT                                {ECO:0000305}.
FT   CONFLICT    246    246       A -> E (in Ref. 1; AAC51914).
FT                                {ECO:0000305}.
FT   CONFLICT    262    262       A -> S (in Ref. 1; AAC51914).
FT                                {ECO:0000305}.
FT   CONFLICT    706    706       F -> S (in Ref. 1; AAC51914).
FT                                {ECO:0000305}.
FT   CONFLICT    731    731       T -> P (in Ref. 1; AAC51914).
FT                                {ECO:0000305}.
FT   CONFLICT    810    810       S -> A (in Ref. 2; CAA90428).
FT                                {ECO:0000305}.
FT   CONFLICT    824    824       A -> P (in Ref. 2; CAA90428).
FT                                {ECO:0000305}.
FT   CONFLICT    871    871       I -> P (in Ref. 1; AAC51914).
FT                                {ECO:0000305}.
FT   CONFLICT    929    929       I -> F (in Ref. 1; AAC51914).
FT                                {ECO:0000305}.
FT   CONFLICT   1059   1059       K -> R (in Ref. 3; CAD38536).
FT                                {ECO:0000305}.
FT   HELIX       914    923       {ECO:0000244|PDB:1DJL}.
FT   STRAND      925    931       {ECO:0000244|PDB:1DJL}.
FT   HELIX       933    938       {ECO:0000244|PDB:1DJL}.
FT   HELIX       941    953       {ECO:0000244|PDB:1DJL}.
FT   STRAND      957    962       {ECO:0000244|PDB:1DJL}.
FT   STRAND      967    969       {ECO:0000244|PDB:1DJL}.
FT   HELIX       972    979       {ECO:0000244|PDB:1DJL}.
FT   HELIX       984    986       {ECO:0000244|PDB:1DJL}.
FT   STRAND      987    989       {ECO:0000244|PDB:1DJL}.
FT   HELIX       990    993       {ECO:0000244|PDB:1DJL}.
FT   HELIX       994    999       {ECO:0000244|PDB:1DJL}.
FT   STRAND     1001   1007       {ECO:0000244|PDB:1DJL}.
FT   HELIX      1010   1012       {ECO:0000244|PDB:1DJL}.
FT   HELIX      1015   1018       {ECO:0000244|PDB:1DJL}.
FT   TURN       1023   1026       {ECO:0000244|PDB:1DJL}.
FT   HELIX      1032   1034       {ECO:0000244|PDB:1DJL}.
FT   STRAND     1035   1045       {ECO:0000244|PDB:1DJL}.
FT   HELIX      1055   1058       {ECO:0000244|PDB:1DJL}.
FT   STRAND     1062   1067       {ECO:0000244|PDB:1DJL}.
FT   HELIX      1069   1081       {ECO:0000244|PDB:1DJL}.
SQ   SEQUENCE   1086 AA;  113896 MW;  8A437658CA0EB41B CRC64;
     MANLLKTVVT GCSCPLLSNL GSCKGLRVKK DFLRTFYTHQ ELWCKAPVKP GIPYKQLTVG
     VPKEIFQNEK RVALSPAGVQ NLVKQGFNVV VESGAGEASK FSDDHYRVAG AQIQGAKEVL
     ASDLVVKVRA PMVNPTLGVH EADLLKTSGT LISFIYPAQN PELLNKLSQR KTTVLAMDQV
     PRVTIAQGYD ALSSMANIAG YKAVVLAANH FGRFFTGQIT AAGKVPPAKI LIVGGGVAGL
     ASAGAAKSMG AIVRGFDTRA AALEQFKSLG AEPLEVDLKE SGEGQGGYAK EMSKEFIEAE
     MKLFAQQCKE VDILISTALI PGKKAPVLFN KEMIESMKEG SVVVDLAAEA GGNFETTKPG
     ELYIHKGITH IGYTDLPSRM ATQASTLYSN NITKLLKAIS PDKDNFYFDV KDDFDFGTMG
     HVIRGTVVMK DGKVIFPAPT PKNIPQGAPV KQKTVAELEA EKAATITPFR KTMSTASAYT
     AGLTGILGLG IAAPNLAFSQ MVTTFGLAGI VGYHTVWGVT PALHSPLMSV TNAISGLTAV
     GGLALMGGHL YPSTTSQGLA ALAAFISSVN IAGGFLVTQR MLDMFKRPTD PPEYNYLYLL
     PAGTFVGGYL AALYSGYNIE QIMYLGSGLC CVGALAGLST QGTARLGNAL GMIGVAGGLA
     ATLGVLKPGP ELLAQMSGAM ALGGTIGLTI AKRIQISDLP QLVAAFHSLV GLAAVLTCIA
     EYIIEYPHFA TDAAANLTKI VAYLGTYIGG VTFSGSLIAY GKLQGLLKSA PLLLPGRHLL
     NAGLLAASVG GIIPFMVDPS FTTGITCLGS VSALSAVMGV TLTAAIGGAD MPVVITVLNS
     YSGWALCAEG FLLNNNLLTI VGALIGSSGA ILSYIMCVAM NRSLANVILG GYGTTSTAGG
     KPMEISGTHT EINLDNAIDM IREANSIIIT PGYGLCAAKA QYPIADLVKM LTEQGKKVRF
     GIHPVAGRMP GQLNVLLAEA GVPYDIVLEM DEINHDFPDT DLVLVIGAND TVNSAAQEDP
     NSIIAGMPVL EVWKSKQVIV MKRSLGVGYA AVDNPIFYKP NTAMLLGDAK KTCDALQAKV
     RESYQK
//
